
    
      By enrolling patients with unresectable Portal venous tumor emboli adapted to enrolled
      criteria, this study will document for the first time the safety and the short and long term
      efficacy of percutaneous or intraoperative IRE for unresectable Portal venous tumor emboli.
    
  